Improvement of eradication therapy in children with duodenal ulcer associated with Helicobacter pylori

dc.contributor.author	Sorokman, Tamila V.
dc.contributor.author	Sokolnyk, Snizhana V.
dc.contributor.author	Moldovan, Pavlo M.
dc.contributor.author	Chernei, Nadiia Ya.
dc.contributor.author	Ostapchuk, Valentuna G.
dc.date.accessioned	2023-02-26T18:42:51Z
dc.date.available	2023-02-26T18:42:51Z
dc.date.issued	2022
dc.identifier.other	DOI: 10.36740/WLek202201212
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/20700
dc.description.abstract	The aim: To evaluate the efficacy of the drug VitD children with H.pylori-associated duodenal ulcer. Conclusions: Due to the reduced level of serum VitD in children with H. pylori-associated DU, it is advisable to include in the treatment regimen the adjuvant component of AHBT in the form of VitD. Predictors of effective eradication of H. pylori are CagA (+) strain of H. pylori, duration of infection and VitD level.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	Wiadomości Lekarskie	uk_UA
dc.subject	children	uk_UA
dc.subject	H. pylori	uk_UA
dc.subject	duodenal ulcer	uk_UA
dc.subject	vitamin D	uk_UA
dc.subject	eradication therapy	uk_UA
dc.title	Improvement of eradication therapy in children with duodenal ulcer associated with Helicobacter pylori	uk_UA
dc.type	Article	uk_UA